Umfangreiches Projektportfolio mit globalen Sponsoren

Das umfassende klinische Forschungsorganisation-Dienstleistungsportfolio von OCT umfasst über 300 klinische Studien in den Phasen I-IV in 29 Therapiegebieten.

Rückruf anfordern

Das OCT-Team führt seit 2005 klinische Studien durch. Wir leiten aktiv Projekte in Europa und den GUS-Staaten und unterstützen unsere Kunden von der Forschungsplanung bis zur Arzneimittelzulassung.

Seit 2005 war OCT an mehr als 300 Komplettservice-Projekten und individuellen klinischen Entwicklungsdienstleistungen beteiligt. Diese umfangreiche Erfahrung ermöglicht es uns, potenzielle Risiken bereits in der ersten Phase der Projektplanung abzuschätzen und sie zu vermeiden.


Projekte
Patienten

Experience by Therapeutic Area

Experience by Phases

Knotenpunkt für therapeutische Erfahrung

Alle Therapiegebiete
Indications
Phase
Year
Type of Trial
Healthy Volunteers
I
2023
Interventional
Healthy volunteers
Bioequivalence
2023
Interventional
Functional Dyspepsia
III
2023
Interventional
Pain
I
2023
Interventional
Cervical Intraepithelial Neoplasia (CIN)
III
2023
Interventional
Dermatomycosis
III
2023
Interventional
Polycystic Kidney Disease
III
2022
Interventional
Healthy volunteers
Bioequivalence
2022
Interventional
Sore Throat
III
2022
Interventional
Head & Neck Cancer
III
2022
Interventional
Healthy Volunteers
Bioequivalence
2022
Interventional
Ulcerative Colitis
III
2022
Interventional
Pyodermia
III
2022
Interventional
Influenza
III
2022
Interventional
COVID-19 Vaccine
III
2022
Interventional
Post-COVID-19 Pneumofibrosis
III
2021
Interventional
COVID-19 Vaccine
III
2021
Interventional
Healthy Volunteers
Bioequivalence
2021
Interventional
Healthy Volunteers
Bioequivalence
2021
Interventional
Healthy Volunteers
Bioequivalence
2021
Interventional
Erectile Dysfunction
III
2021
Interventional
Prevention of Peritoneal Commissures
III
2021
Interventional
Breast Cancer
III
2021
Interventional
Atopic dermatitis
N/A
2021
Non-interventional
Esophagitis
III
2021
Interventional
Healthy volunteers
Bioequivalence
2021
Interventional
Moscquito Bites
III
2021
Interventional
Diabetic Polyneuropathy
III
2021
Interventional
Acute Back Pain
III
2021
Interventional
Rheumatoid Arthritis
I
2021
Interventional
Prophylaxis of Meningococcal Infection
III
2021
Interventional
COVID-19 Vaccine
III
2020
Interventional
Dyspepsia
III
2020
Interventional
Healthy Volunteers
Bioequivalence
2020
Interventional
Healthy Volunteers
Bioequivalence
2020
Interventional
Healthy Volunteers
Bioequivalence
2020
Interventional
Healthy Volunteers
Bioequivalence
2020
Interventional
Recurrent Vulvovaginal Candidiasis
III
2020
Interventional
Follicular Lymphoma
III
2020
Interventional
Ulcerative Colitis
III
2020
Interventional
Nail Mycosis
III
2020
Interventional
Atopic Dermatitis
II
2020
Interventional
Healthy Volunteers
Bioequivalence
2020
Interventional
Ulcerative Colitis
II
2020
Interventional
Netherton Syndrome
III
2020
Interventional
COVID-19 Vaccine
III
2020
Interventional
COVID-19 Vaccine
III
2020
Interventional
Healthy volunteers
Bioequivalence
2020
Interventional
Pelvic Inflammatory Disease
III
2020
Interventional
Ulcerative Colitis
II
2020
Interventional
Atopic Dermatitis
III
2020
Interventional
Nail Mycosis
II
2020
Interventional
Solid Tumors
III
2020
Interventional
Gastritis
III
2020
Interventional
Viral Hepatitis
III
2020
Interventional
Psoriasis
III
2020
Interventional
Osteoarthrosis
III
2020
Interventional
Acute Respiratory Viral Infection
III
2020
Interventional
Acute Back Pain
III
2020
Interventional
Nosocomial Pneumonia
III
2019
Interventional
Peritoneal Commissures
III
2019
Interventional
Healthy Volunteers
Bioequivalence
2019
Interventional
Acute Respiratory Viral Infection
III
2019
Interventional
Osteoarthritis Knee Pain
III
2019
Interventional
Back Pain
III
2019
Interventional
Gastritis
I
2019
Interventional
Chronic Discogenic Low Back Pain
II
2019
Interventional
Chron's Disease
III
2019
Interventional
Chronic Myeloid Leucosis
II
2019
Interventional
Multiple Sclerosis
III
2019
Interventional
Breast Cancer
III
2019
Interventional
Musculo-Sceletal Injuries
III
2019
Interventional
Chronic Myeloid Leukemia
III
2019
Interventional
Biliary Colic
III
2019
Interventional
Acute Back Pain
III
2019
Interventional
Nutrition
N/A
2019
Non-interventional
Pain
IV
2019
Interventional
Nosocomial Pneumonia
III
2019
Interventional
Female Sexual Arousal Disorder
N/A
2019
Non-interventional
Nasolabial Folds
IV
2019
Interventional
Healthy Volunteers
Bioequivalence
2019
Interventional
Healthy Volunteers
Bioequivalence
2018
Interventional
Erectile Dysfunction
III
2018
Interventional
Glabellar Lines
III
2018
Interventional
Ulcerative Сolitis
III
2018
Interventional
Atherosclerosis
II
2018
Interventional
Healthy Volunteers
I
2018
Interventional
Craniocerebral Injury
III
2018
Interventional
Advanced Solid Tumor
I
2018
Interventional
Glaucoma
III
2018
Interventional
Venous Thrombosis
II
2018
Interventional
Acute Viral Respiratory Infections
III
2018
Interventional
Acute Hemorrhoids
III
2018
Interventional
Recessive Dystrophic Epidermolysis Bullosa
I
2018
Interventional
Extensive Psoriasis Vulgaris
II
2018
Interventional
Gastro-intestinal Infections
III
2018
Interventional
Squamous Cell Cancer
II
2018
Interventional
NSCLC (with high PD-L1 expression)
I
2018
Interventional
Osteoarthrosis
I
2018
Interventional
Intensive Care
II
2017
Interventional
Influenza Vaccine
III
2017
Interventional
Rheumatoid Arthritis
III
2017
Interventional
EGFR-Mutant NSCLC
II
2017
Interventional
Ulcerative Colitis
I
2017
Interventional
Solid Tumors
I
2017
Interventional
Hematological Cancers
I
2017
Interventional
Tuberculosis
I
2017
Interventional
Acute Diarrhea
III
2017
Interventional
Diabetic Polyneuropathy
II
2017
Interventional
Osteoarthrosis
IV (Post-marketing)
2017
Non-interventional
Colorectal Cancer
III
2017
Interventional
Non-Hodgkin’s Lymphoma
II
2017
Interventional
Atherosclerosis
III
2017
Interventional
Influenza
I
2017
Interventional
Female Sexual Arousal Disorder
III
2017
Interventional
Seborrheic Dermatitis
III
2017
Interventional
Cerebrovascular Circulation Disorders
N/A
2017
Interventional
Arterial Hypertension
N/A
2017
Non-interventional
Chronic HCV Gt1b Infection and Compensated Liver C
N/A
2017
Non-interventional
Idiopathic Pulmonary Fibrosis
III
2017
Interventional
Acute Upper Respiratory Infections
III
2017
Interventional
Post Traumatic Inflamation of Soft Tissues
III
2017
Interventional
Arterial Hypertension
Bioequivalence
2017
Interventional
Arterial Hypertension
Bioequivalence
2017
Interventional
Arterial Hypertension
Bioequivalence
2017
Interventional
Post Traumatic Inflamation of Soft Tissues
II
2017
Interventional
Influenza
II
2017
Interventional
Recurrent Glioblastoma
II
2017
Interventional
Diabetes Mellitus
IV
2017
Non-interventional
Chronic Lymphocytic Leukemia
N/A
2017
Non-interventional
Arterial Hypertension
III
2017
Interventional
Influenza Vaccine
II
2016
Interventional
Acute Dental Pain
III
2016
Interventional
Rheumatoid Arthritis
III
2016
Interventional
Ulcerative Proctitis
III
2016
Interventional
Influenza Vaccine
IV (Post-marketing)
2016
Non-interventional
Chronic Delta Hepatitis
II
2016
Interventional
Tuberculosis
II
2016
Interventional
Idiopathic Pulmonary Fibrosis
II
2016
Interventional
Influenza Vaccine
I
2016
Interventional
Cough on Acute Upper Respiratory Infection
III
2016
Interventional
Tuberculosis
II
2016
Interventional
Rheumatoid Arthritis
III
2016
Interventional
Unspecified Adult Solid Tumors
I
2016
Interventional
Chronic Lymphocytic Leukemia
III
2016
Interventional
Breast Cancer
III
2016
Interventional
Healthy Volunteers
Bioequivalence
2016
Interventional
Acute Gout
II
2016
Interventional
Healthy Volunteers
Bioequivalence
2016
Interventional
Healthy Volunteers
Bioequivalence
2016
Interventional
Post Traumatic Inflamation of Soft Tissues
III
2016
Interventional
Acute Non-Specific Lower Back Pain
III
2016
Interventional
Healthy Volunteers
I
2016
Interventional
Meniere’s Disease and/or Vestibular Vertigo
III
2016
Interventional
Healthy volunteers
I
2016
Interventional
Prostate Cancer
I
2016
Interventional
Chronic Hepatitis C
IV
2016
Non-interventional
Part of Therapy for HIV Patients
Bioequivalence
2016
Interventional
Primary Dysmenorrhoea
III
2016
Interventional
Spondylarthritis (Ankylosing Spondylitis and Psori)
IV
2016
Non-interventional
Atopic Eczema
III
2016
Interventional
Healthy Volunteers
Bioequivalence
2015
Interventional
Healthy Volunteers
Bioequivalence
2015
Interventional
Anal Fissure
III
2015
Interventional
Cardiac Monitoring
III
2015
Interventional
Tuberculosis
I
2015
Interventional
Breast Cancer
III
2015
Interventional
Colorectal Cancer
II
2015
Interventional
Rheumatoid Arthritis
III
2015
Interventional
Healthy Volunteers
I
2015
Interventional
Rheumatoid Arthritis
III
2015
Interventional
Breast Cancer
II
2015
Interventional
Chronic Myeloid Leukemia
I
2015
Interventional
Healthy Volunteers
I
2015
Interventional
HIV
IV (Post-marketing)
2015
Non-interventional
Astenospermia
II
2015
Interventional
Breast Cancer
III
2015
Interventional
Locally Advanced Epithelial Ovarian Cancer, Primar
II
2015
Interventional
Mild Cognitive Impairment
III
2015
Interventional
Non-Small Cell Lung Cancer
III
2015
Interventional
Сhronic Myeloid Leukemia
II
2015
Interventional
Healthy Volunteers
Bioequivalence
2015
Interventional
Healthy Volunteers
Bioequivalence
2015
Interventional
Healthy Volunteers
Bioequivalence
2015
Interventional
Psoriasis Vulgaris
I
2015
Interventional
Renal Colics
III
2015
Interventional
Chronic Blepharoconjunctivitis
III
2015
Interventional
Female Sexual Arousal Disorder
II
2015
Interventional
Bone Metastases of Breast Cancer
II
2015
Interventional
Chronic Myeloid Leukemia
III
2015
Interventional
Chronic Hepatitis B
II
2015
Interventional
Sore Throat
III
2015
Interventional
Heart Failure
III
2014
Interventional
Vestibular Vertigo
III
2014
Interventional
Infusion Therapy
III
2014
Interventional
Knee Replacement
III
2014
Interventional
Community Aquired Pneumonia
III
2014
Interventional
Schizophrenia
II
2014
Interventional
Breast Cancer
I
2014
Interventional
Chronic Obstructive Pulmonary Disease
II
2014
Interventional
Complicated Urinary Tract Infections
III
2014
Non-interventional
Schizophrenia
III
2014
Interventional
Solid Tumors
I
2014
Interventional
Acute Myeloid Leucosis
I
2014
Interventional
HIV
II
2014
Interventional
Hypoxic Central Nervous System Injury
III
2014
Interventional
Alzheimer Disease
IV (Post-marketing)
2014
Interventional
Parenteral Nutrition
III
2014
Interventional
Corneal Injury
I
2014
Interventional
Deep Vein Thrombosis
III
2014
Interventional
Healthy Volunteers
I
2014
Interventional
Metastatic Colon Cancer
III
2014
Interventional
B-Cell Lymphoma
III
2014
Interventional
Healthy volunteers
I
2014
Interventional
Advanced Melanoma
I
2014
Interventional
Tuberculosis
III
2014
Interventional
Diabetic Neuropathy
III
2014
Interventional
Hepatitis B
Bioequivalence
2014
Interventional
Back Pain
III
2014
Interventional
Healthy Volunteers
N/A
2014
Interventional
Diabetes Mellitus Type 2
IV (Post-marketing)
2013
Non-interventional
Healthy Volunteers
Bioequivalence
2013
Interventional
Healthy Volunteers
Bioequivalence
2013
Interventional
Breast Cancer
IV (Post-marketing)
2013
Non-interventional
Chronic Obstructive Pulmonary Disease
IV (Post-marketing)
2013
Non-interventional
Chronic Prostatitis
IV (Post-marketing)
2013
Non-interventional
Diabetes Mellitus Type 2
I
2013
Interventional
Essential Hypertension
III
2013
Interventional
LV Insufficiency
IV (Post-marketing)
2013
Interventional
Metastatic Cancer
I
2013
Interventional
Non-small Cell Lung Cancer
IV (Post-marketing)
2013
Non-interventional
Multiple Drug Resistant Tuberculosis
IV (Post-marketing)
2013
Interventional
Multiple Sclerosis
III
2013
Interventional
Solid Tumors
I
2013
Interventional
Community Aquired Pneumonia
III
2013
Interventional
Ovarian Cancer
I
2013
Interventional
Outpatient Pneumonia
IV (Post-marketing)
2013
Non-interventional
Recurrent Upper Respiratory Tract Infections
III
2013
Interventional
Respiratory Tract Infection
IV (Post-marketing)
2013
Non-interventional
Rheumatoid Arthritis
I
2013
Interventional
Rheumatoid Arthritis
III
2013
Interventional
Endometrial Carcinoma
II
2013
Interventional
Sore Throat
III
2013
Interventional
Arterial Hypertension
IV (Post-marketing)
2013
Non-interventional
Vaginitis
IV (Post-marketing)
2013
Non-interventional
Dislipidemia
I
2013
Interventional
Diarrhea
IV (Post-marketing)
2013
Non-interventional
Parenteral Nutrition
III
2013
Interventional
Ulcerative Proctitis
II
2013
Interventional
Chronic Prostatitis
IV (Post-marketing)
2013
Non-interventional
Acute Otitis
IV (Post-marketing)
2013
Non-interventional
Mucoviscidosis
I
2013
Interventional
Non-small Cell Lung and Epithelial Ovarian Cancer
I
2013
Interventional
Advanced Melanoma
I
2013
Interventional
Prophylaxis of Thromboembolic Complication in Knee
II
2013
Interventional
Advanced Melanoma
I
2013
Interventional
Thoracic Aortic Aneurysm
I
2013
Interventional
Aneurysmal Subarachnoid Hemorrhage
I
2013
Interventional
Hepatitis B
I
2013
Interventional
Diabetic Foot Ulcer
N/A
2013
Interventional
Chronic Hepatitis B
II
2012
Interventional
Multiple Sclerosis
IV (Post-marketing)
2012
Non-interventional
Alcohol Abuse
II
2012
Interventional
Anxiety Disorder
II
2012
Interventional
Healthy Volunteers
Bioequivalence
2012
Interventional
Healthy Volunteers
Bioequivalence
2012
Interventional
Multiple Sclerosis
I
2012
Interventional
Intensive Care
III
2012
Interventional
Acute Myeloid Leukemia
II
2012
Interventional
Atrial Fibrillation
IV (Post-marketing)
2012
Non-interventional
Healthy Volunteers
Bioequivalence
2012
Interventional
Healthy Volunteers
Bioequivalence
2012
Interventional
Breast Cancer
II
2012
Interventional
Chronic Kidney Disease
III
2012
Interventional
Coronary Artery Disease
III
2012
Interventional
Deep Vein Thrombosis
III
2012
Interventional
LV insufficiency
IV (Post-marketing)
2012
Interventional
Multiple Myeloma
III
2012
Interventional
Sore Throat
III
2012
Interventional
Thromboembolic Events
IV (Post-marketing)
2012
Non-interventional
HBeAg Negative Chronic Hepatitis B
II
2012
Interventional
Pregnancy Exposure
IV (Post-marketing)
2012
Non-interventional
Pain
III
2012
Interventional
Healthy volunteers
Bioequivalence
2012
Interventional
Ocular Inflammation Following Cataract Surgery
III
2012
Interventional
Asthma
III
2012
Interventional
Sore Throat
III
2012
Interventional
Biliary Colic
III
2012
Interventional
Hepatocellular Carcinoma
N/A
2012
Interventional
Vascular Dementia
N/A
2012
Interventional
Healthy Volunteers
Bioequivalence
2011
Interventional
Infant Colic
II
2011
Interventional
Metastatic Breast Cancer
II
2011
Interventional
Asthma
III
2011
Interventional
Back Pain
III
2011
Interventional
Healthy Volunteers
Bioequivalence
2011
Interventional
Biliary Colic
III
2011
Interventional
Bladder Cancer
II
2011
Interventional
Breast Cancer
II
2011
Interventional
Central Catheter's Maintanance
III
2011
Interventional
Gout
III
2011
Interventional
Gynecology
III
2011
Interventional
Isolated Systolic Hypertension
III
2011
Interventional
Locally Advanced Pancreatic Cancer
II
2011
Interventional
Multiple Myeloma
III
2011
Interventional
Rheumatoid Arthritis
IV (Post-marketing)
2011
Interventional
Solid Tumors
I
2011
Interventional
Stable Angina
IV (Post-marketing)
2011
Interventional
Essential Arterial Hypertension
III
2011
Interventional
Parenteral Nutrition
III
2011
Interventional
Ischemic Foot Ulcers
III
2011
Interventional
Stable Angina
IV
2011
Interventional
Central Catheter's Maintanance
III
2011
Interventional
Wound Healing
II
2011
Interventional
Sore Throat
II
2010
Interventional
Colorectal Cancer
III
2010
Interventional
Colorectal Cancer
II
2010
Interventional
Endometrial Carcinoma
II
2010
Interventional
Intestinal Colics
IV (Post-marketing)
2010
Non-interventional
Major Orthopedic Surgery
III
2010
Interventional
Rhinitis
IV (Post-marketing)
2010
Non-interventional
Solid Tumors
II
2010
Interventional
Colorectal Anastomosis
I
2010
Interventional
Colorectal Cancer
III
2010
Interventional
Head and Neck Cancer
III
2010
Interventional
Mastocytosis
II
2010
Interventional
Acute Bronchitis
IV (Post-marketing)
2010
Non-interventional
Liver disorder
IV (Post-marketing)
2010
Non-interventional
Breast Cancer
II
2010
Interventional
Rheumatoid Arthritis
II
2009
Interventional
Breast Cancer
III
2009
Interventional
Diabetes Mellitus
II
2009
Interventional
Erectile Dysfunction
III
2009
Interventional
Hypothyreosis
IV (Post-marketing)
2009
Non-interventional
Breast Cancer
II
2009
Interventional
Pulmonology/Pediatrics, Bronchitis, Pneumonia, AS
IV (Post-marketing)
2009
Non-interventional
Eradication of H. pylori
II
2009
Interventional
Hepatic cirrhosis
III
2009
Interventional
Eradication of H. Pylori
II
2009
Interventional
Pain
II
2008
Interventional
Crohn's Disease
II
2008
Interventional
Diabetes Mellitus
II
2008
Interventional
Brain Vessel Aneurism Rupture
III
2008
Interventional
Ovarian Cancer
III
2008
Interventional
Prostate Cancer
II
2008
Interventional
Solid Tumors
I
2008
Interventional
Age-related Macular Degeneration
I
2008
Interventional
Rheumatoid Arthritis
II
2008
Interventional
Bone Metastases, Pain
II
2008
Interventional
Prostate Cancer
II
2008
Interventional
Prostate Cancer
II
2008
Interventional
Prostate Cancer
II
2008
Interventional
Acute Myeloid Leukosis
II
2007
Interventional
Acute Myocardial Infarction
IV (Post-marketing)
2007
Interventional
Healthy Volunteers
Bioequivalence
2007
Interventional
Breast Cancer
II
2007
Interventional
Breast Cancer
II
2007
Interventional
Breast Cancer, Neutropenia
III
2007
Interventional
Hepatic Metastases
II
2007
Interventional
Irritable Bowel Syndrome
III
2007
Interventional
Pain
II
2007
Interventional
Prostate Cancer
II
2007
Interventional
Healthy Volunteers
Bioequivalence
2007
Interventional
Acne
II
2006
Interventional
Nutrition
III
2006
Interventional
Acute Heart Failure
III
2006
Interventional
Prostate Cancer
III
2006
Interventional
Immunotherapy in Renal Cell Carcinoma
III
2005
Interventional
T-cell Leukemia
II
2005
Interventional
Mehr anzeigen
Rückruf anfordern

Thank you for your request!
Our team will respond to you within 24 hours.